神经病理学
神经炎症
代谢综合征
胰岛素抵抗
疾病
氧化应激
血脂异常
神经科学
医学
发病机制
生物信息学
阿尔茨海默病
内科学
糖尿病
生物
内分泌学
作者
Haydar M. Al-kuraishy,Majid S. Jabir,Ali K. Albuhadily,Ali I. Al‐Gareeb,Mayyadah F. Rafeeq
标识
DOI:10.1016/j.arr.2023.102084
摘要
It has been illustrated that metabolic syndrome (MetS) is associated with Alzheimer disease (AD) neuropathology. Components of MetS including central obesity, hypertension, insulin resistance (IR), and dyslipidemia adversely affect the pathogenesis of AD by different mechanisms including activation of renin-angiotensin system (RAS), inflammatory signaling pathways, neuroinflammation, brain IR, mitochondrial dysfunction, and oxidative stress. MetS exacerbates AD neuropathology, and targeting of molecular pathways in MetS by pharmacological approach could a novel therapeutic strategy in the management of AD in high risk group. However, the underlying mechanisms of these pathways in AD neuropathology are not completely clarified. Therefore, this review aims to elucidate the association between MetS and AD regarding the oxidative and inflammatory mechanistic pathways.
科研通智能强力驱动
Strongly Powered by AbleSci AI